비만과 혈당 상승을 동반한 환자에서 한의 치료와 저탄수화물 식단의 체중 감량 및 HbA1c 개선 효과 : 다기관 후향적 연구
Effects of Korean Medicine Treatment and a Low-Carbohydrate Diet on Weight Loss and Glycemic Control in Patients with Obesity and Elevated Blood Glucose: A Multicenter Retrospective Study
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: This study evaluates the effects of Korean medicine combined with a low-carbohydrate diet (LCD) on weight loss and glycemic control in patients with elevated hemoglobin A1c (HbA1c≥5.7%) from Daeat Korean Medicine Clinics (Seoul, Incheon Bupyeong). Methods: Among 1,563 screened patients, the medical records of 39 who had received Korean medicine treatment for at least 60 days and had HbA1c measurements taken≥60 days apart were analyzed. Interventions included herbal medicine, pharmacopuncture, and carbohydrate restriction (≤50 g/day). Results: Overall HbA1c decreased (-0.78±1.36%), with 12 patients improving to lower glycemic categories. Patient weight (-4.61±4.47 kg), body mass index (-5.24%), and body fat mass (-4.03±3.35 kg) also saw significant reductions. Conclusion: Korean medicine and a LCD may improve weight and glycemic control, offering a complementary strategy for obesity and hyperglycemia management.
Abstract
Objective: This study evaluates the effects of Korean medicine combined with a low-carbohydrate diet (LCD) on weight loss and glycemic control in patients with elevated hemoglobin A1c (HbA1c≥5.7%) from Daeat Korean Medicine Clinics (Seoul, Incheon Bupyeong). Methods: Among 1,563 screened patients, the medical records of 39 who had received Korean medicine treatment for at least 60 days and had HbA1c measurements taken≥60 days apart were analyzed. Interventions included herbal medicine, pharmacopuncture, and carbohydrate restriction (≤50 g/day). Results: Overall HbA1c decreased (-0.78±1.36%), with 12 patients improving to lower glycemic categories. Patient weight (-4.61±4.47 kg), body mass index (-5.24%), and body fat mass (-4.03±3.35 kg) also saw significant reductions. Conclusion: Korean medicine and a LCD may improve weight and glycemic control, offering a complementary strategy for obesity and hyperglycemia management.